back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-09 18:37 Tx date 2026-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-63,236.60
-1,190 vol $53.14 each |
1,455 | |
| Filed 2026-06-09 18:35 Tx date 2026-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-70,251.08
-1,322 vol $53.14 each |
29,787 | |
| Filed 2026-06-05 17:33 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,593 vol |
1,593 | |
| Filed 2026-06-05 17:33 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,507 vol |
133,036 | |
| Filed 2026-06-05 17:30 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,645 vol |
31,109 | |
| Filed 2026-06-05 17:25 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,645 vol |
0 | |
| Filed 2026-06-05 17:22 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Machado, Patrick
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,593 vol |
1,593 | |
| Filed 2026-06-05 17:21 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Machado, Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,507 vol |
109,536 | |
| Filed 2026-06-05 17:18 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Machado, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,645 vol |
2,645 | |
| Filed 2026-06-05 17:18 Tx date 2020-11-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Machado, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-05 17:17 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Machado, Patrick
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,645 vol |
0 | |
| Filed 2026-06-05 15:52 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Gover, Justin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,593 vol |
1,593 | |
| Filed 2026-06-05 15:51 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Gover, Justin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,507 vol |
71,061 | |
| Filed 2026-06-05 15:49 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Gover, Justin
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,645 vol |
2,645 | |
| Filed 2026-06-05 15:49 Tx date 2023-08-08 |
$XENE
Xenon Pharmaceuticals Inc. |
Gover, Justin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-05 15:48 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Gover, Justin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,645 vol |
0 | |
| Filed 2026-06-05 15:42 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,593 vol |
1,593 | |
| Filed 2026-06-05 15:41 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,507 vol |
96,036 | |
| Filed 2026-06-05 15:38 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,645 vol |
2,645 | |
| Filed 2026-06-05 15:37 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Garofalo, Elizabeth
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,645 vol |
0 |